Owners of the former New England pharmacy that produced tainted steroids blamed for a fungal meningitis outbreak in 2012 agreed to pay $ 100 million to victims and creditors.
Modern Healthcare Breaking News
Deal creates fund for victims of meningitis outbreak tied to compounding pharmacy
No comments:
Post a Comment